Groupama Asset Managment Vertex Pharmaceuticals Inc Transaction History
Groupama Asset Managment
- $5.01 Trillion
- Q1 2025
A detailed history of Groupama Asset Managment transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Groupama Asset Managment holds 51,933 shares of VRTX stock, worth $19.5 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
51,933
Previous 43,479
19.44%
Holding current value
$19.5 Million
Previous $17.4 Billion
47.36%
% of portfolio
0.51%
Previous 0.35%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,828Shares Held
232MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$10.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$8.81 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.99 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.45 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.42 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $96.3B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...